Pemetrexed for the treatment of non-small-cell lung cancer

This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta124

1 Guidance

1.1 Pemetrexed is not recommended for the treatment of locally advanced or metastatic non-small-cell lung cancer.

1.2 People currently receiving pemetrexed should have the option to continue therapy until they and their clinicians consider it appropriate to stop.